EUVIMEDEUVIMED entdecken
Open Access

Cost–effectiveness of cetuximab combined with radiotherapy versus radiotherapy alone in locally advanced head and neck cancer in Spain

Ruth Álvarez Cabellos, Jon Cacicedo, Susana Redondo Capafons, Heidi De Los Santos Real, Miriam Brines Julián, Darío Rubio-Rodríguez, Carlos Rubio-Terrés

Journal of Comparative Effectiveness Research · 2025

DOI: 10.57264/cer-2024-0116 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Comparative Effectiveness Research, 2025. Verfasst von Ruth Álvarez Cabellos und 6 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology Department, Virgen de la Salud University Hospital, Avda. De Barber, 30, 45005, Toledo, Spain. Hauptthemen laut MEDLINE: Cetuximab, Head and Neck Neoplasms, Antineoplastic Agents, Immunological, Chemoradiotherapy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To estimate the cost–effectiveness of cetuximab in combination with radiotherapy compared with radiotherapy alone, for the treatment of locally advanced head and neck cancer patients in Spain.

Methods

A probabilistic Markov model (second-order Monte Carlo simulation) with a five-year time horizon and quarterly Markov cycles was performed from the perspective of the Spanish National Health System (NHS).

Results

The additional cost and quality-adjusted life-year (QALY) gain per patient receiving radiotherapy in combination with cetuximab compared with radiotherapy alone was €4356 (95% CI: €4350–4362) and 0.2380 (95% CI: 0.2370–0.2391) QALY, respectively. The incremental cost per QALY gain was €18,303 (95% CI: €18,243–18,354) with a probability of cost–effectiveness of 65.4% for a willingness to pay of €30,000 per QALY gained.

Conclusion

According to the results of this analysis, the addition of cetuximab to radiotherapy would be a cost-effective alternative to radiotherapy alone in the treatment of locally advanced head and neck cancer in Spain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CetuximabHead and Neck NeoplasmsAntineoplastic Agents, ImmunologicalChemoradiotherapyHumansCost-Benefit AnalysisSpainQuality-Adjusted Life YearsMarkov ChainsMonte Carlo Method

Stichwörter der Autor:innen

Spaincetuximabcost–effectivenesslocally advanced head and neck cancerradiotherapy

Substanzen

CetuximabAntineoplastic Agents, Immunological

Autor:innen und Institutionen

  • Medical Oncology Department, Virgen de la Salud University Hospital, Avda. De Barber, 30, 45005, Toledo, Spain.
  • Radiation Oncology Department, Cruces University Hospital/Instituto de Investigación Biobizkaia, Pza. Cruces, s/n, 48903, Baracaldo, Spain.
  • Parc Taulí University Hospital, Pharmacy Department, Parc Taulí 1, 08208, Sabadell, Spain.
  • Merck, SLU, C/María de Molina, 40, 28006, Madrid, Spain, an affiliate of Merck KGaA.
  • Health Value, HE Department, C/Virgen de Aránzazu, 21, 28034, Madrid, Spain.

Zitieren

APA

Cabellos, R. Á., Cacicedo, J., Capafons, S. R., Los Santos Real, H., Julián, M. B., Rubio-Rodríguez, D., & Rubio-Terrés, C. (2025). Cost–effectiveness of cetuximab combined with radiotherapy versus radiotherapy alone in locally advanced head and neck cancer in Spain. Journal of Comparative Effectiveness Research. https://doi.org/10.57264/cer-2024-0116

Vancouver

Cabellos RÁ, Cacicedo J, Capafons SR, Los Santos Real H, Julián MB, Rubio-Rodríguez D, et al. Cost–effectiveness of cetuximab combined with radiotherapy versus radiotherapy alone in locally advanced head and neck cancer in Spain. Journal of Comparative Effectiveness Research. 2025. doi:10.57264/cer-2024-0116

BibTeX
@article{Cabellos2025,
  author = {Cabellos, Ruth Álvarez and Cacicedo, Jon and Capafons, Susana Redondo and Los Santos Real, Heidi De and Julián, Miriam Brines and Rubio-Rodríguez, Darío and Rubio-Terrés, Carlos},
  title = {Cost–effectiveness of cetuximab combined with radiotherapy versus radiotherapy alone in locally advanced head and neck cancer in Spain},
  journal = {Journal of Comparative Effectiveness Research},
  year = {2025},
  doi = {10.57264/cer-2024-0116}
}
Kostenlos starten →